Projects
Kenya Obstetrical and Gynaecological Society > Projects
COMPLETED PROJECT
FIGO-KOGS Project on prevention of maternal mortality arising from unsafe abortion and improvement of post abortion care
Duration: July 2019 to July 2022
COMPLETED PROJECT
FIGO-KOGS Project on Immediate post partum insertion of intrauterine device (PPIUD)
Duration: Jan 2015 to Sept 2019
ONGOING PROJECT
The AMPLI-PPHI project aims to address key challenges related to access to quality assured drugs for PPH (Post-Partum Haemorrhage)
prevention and management. By identifying barriers, fostering collaboration among advocacy partners, and
advocating for improved PPH care, KOGS is actively working towards reducing maternal mortality rates in
Kenya.
In partnership with esteemed organizations such as the International Federation of Gynaecology and
Obstetrics (FIGO), Jhpiego, and PATH, KOGS is driving forward this important project. Together, we are
determined to make a tangible impact on the lives of women and ensure access to life-saving interventions
during the critical postpartum period.
Duration: 2022 to 2026
ONGOING PROJECT
KOGS is actively involved in the "Prevention of Maternal Mortality from Unsafe Abortion and Post Abortal Care" project. This initiative aims to address the critical issue of unsafe abortions and provide comprehensive post-abortion care to save lives and safeguard women's well-being.
Duration: Jan 2023 to Dec 2023
ONGOING PROJECT
Leadership Development initiative project aims to improve maternal and newborn health outcomes through advocacy and improved care, with a focus on leadership development. KOGS believes that leadership development is key to improving maternal and newborn health outcomes. By providing leaders with the tools and knowledge they need to advocate for evidence-based clinical practice guidelines, we can ensure that best practices are being implemented across the board.
Duration: 2022 to 2025
ONGOING PROJECT
KOGS is proud to be part of a study project focused on "Rhesus Disease Prevention." In collaboration with the (Ministry of Health) and Eldon Biologicals, we will focus on strengthening screening programs, improving access to diagnostic tests, and implementing evidence-based guidelines for effective management of Rhesus Disease.
Duration: June 2023
